Lexicon Pharmaceuticals, Inc. (LXRX) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic…
Source: Yahoo Finance
Sector & Industry
Lexicon Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Lexicon Pharmaceuticals, Inc. at a Glance
| Company | Lexicon Pharmaceuticals, Inc. |
| Ticker | LXRX |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $2.24 |
| Market cap | $996.70M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$0.16 |
| 52-week high | $2.68 |
| 52-week low | $1.05 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.03 |
| Return on equity (ROE) | -40.21% |
| Debt-to-equity | 33.94% |
| Average volume | 3.32M |
| Shares outstanding | 444.96M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 81 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Lexicon Pharmaceuticals, Inc.'s current P/E ratio?
- Lexicon Pharmaceuticals, Inc. (LXRX) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Lexicon Pharmaceuticals, Inc.'s market capitalisation?
- Lexicon Pharmaceuticals, Inc.'s market cap is $996.70M based on our latest snapshot. See how it ranks by market cap →
- What is LXRX's 52-week range?
- Over the past 52 weeks, LXRX has traded between $1.05 and $2.68. What does the 52-week range mean? →
- How volatile is Lexicon Pharmaceuticals, Inc. compared to the market?
- Lexicon Pharmaceuticals, Inc. has a beta of 1.03, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Lexicon Pharmaceuticals, Inc. pay a dividend?
- Lexicon Pharmaceuticals, Inc. does not currently pay a dividend according to our latest data.
- What exchange is LXRX listed on?
- LXRX is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Lexicon Pharmaceuticals, Inc. in?
- Lexicon Pharmaceuticals, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Working out potential returns or position sizes? Our payout and odds calculators handle the maths.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →